Clinical Trial: FST-100 Ophthalmic Suspension in Acute Adenoviral Conjunctivitis

Study Status: Terminated
Recruit Status: Terminated
Study Type: Interventional

Official Title:

Brief Summary: The objective of this study is to evaluate the efficacy of FST-100 (0.1% dexamethasone) Ophthalmic Suspension in the treatment of suspected acute adenoviral conjunctivitis.

Detailed Summary:
Sponsor: Shire

Current Primary Outcome: Clinical cure is defined as a reduction of conjunctival injection and discharge scaled scored each to 0/3. [ Time Frame: 1 year ]

Original Primary Outcome: Same as current

Current Secondary Outcome: Reduction in viral titer by qPCR. Eradication of infectious virus determined by CC-IFA. [ Time Frame: 1 year ]

Original Secondary Outcome: Same as current

Information By: Shire

Dates:
Date Received: July 15, 2009
Date Started: June 2009
Date Completion:
Last Updated: September 14, 2015
Last Verified: September 2012